Ontogenic development of mammalian sleep-wake cycle: Evidence based on the thalamic immunoreactivity pattern of a patient with Morvan’s syndrome


Creative Commons License

Tüzün E., Vincent T., Vincent A.

36th National Congress of Neurology, İstanbul, Türkiye, 01 Kasım 2000, ss.73, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: İstanbul
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.73
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi Adresli: Evet

Özet

INTRODUCTION:

Morvan’s syndrome (Ms) is a rare disease characterised by neuromyotonia (spontaneous muscular activity resulting from repetitive motor unit action potentials of peripheral origin), dysfunction of autonomic nervous system and central nervous system (CNS) involvement (1). The cardinal symptoms of autonomic and central nervous system dysfunction are hyperhidrosis and insomnia, hallucinosis, respectively (2). Some cases with Ms have been suggested to have an autoimmune origin, depending on associated findings such as concurrent myasthenia gravis and other autoimmune disorders, thymoma, serum antibodies to acetylcholine receptors, titin, N-type calcium channels and voltage gated potassium channels, resolution of symptoms by plasmapheresis, thymectomy or immunosuppression (1,3).

Ms cases with insomnia have rarely been investigated with polysomnographic studies (4,5) and anatomical structures involved in pathophysiology of sleep disorder have not been analysed in detail. Other reported major clinical syndromes that can manifest with organic insomnia are vascular, traumatic or degenerative lesions of the brainstem, bilateral stereotatic thalamic injury, trypanosomiasis, Von Economo encephalitis and fatal familial insomnia (5). Lesions of raphe, thalamic or hypothalamic nuclei seem to play an important role in these clinical situations (5).

There are prominent differences between sleep-wake cycles of adults and newborns. The newborn infant spends three quarters of his time asleep, while at adulthood sleep occupies only one third of all the day. The development of sleep and wakefulness is continuous and follows a progressive pattern: first rapid in the perinatal period and until one year of age, then much slower until puberty. Main steps in the ontogenetic development of sleep-wake cycle are the building up of a circadian sleep-wake rhythm, the lengthening of the daytime awakening period, the reduction of REM sleep time and the relative increase of non-REM sleep duration. This ontogenetic process may be observed in almost all mammals (6).

The aim of this study was to identify the anatomical features underlying these differences from an immunological point of view. For this purpose, serum of a 76-year old male patient presenting with neuromyotonia, excessive sweating, salivation, insomnia (Morvan’s syndrome) and pulmonary adenocarcinoma was used. The serum was known to be positive for anti-voltage-gated potassium channel (VGKC) antibodies. Immunohistochemical studies were compared with the results of autoradiographic studies performed with spesific K channel blockers.

 

CASE REPORT:

A 76 year old man

Muscle weakness, fatigue, excessive sweating, salivation, small joint pain, itching erythema and progressive weight loss at age 75.

Three months later à diffuse muscular twitching, episodes of acute confusional syndrome, visual and auditory hallucinations and complex nocturnal behaviour during sleep.

Later à progressive nocturnal insomnia, impairment of memory, constipation, urinary incontinence and excessive lacrymation.

The patient died after a number of plasmapheresis sessions and progressive worsening of all clinical findings.

Neurologic examination à myokymia in the face, tongue, trunk and all limbs, fasciculations, spontaneous and reflex myoclonus, slight muscular atrophy and absence of tendon reflexes. Pin-prick, touch and vibration senses and muscle strength were normal. Plantar reflexes in flexion.

Bedside neuropsychological examination à Psychomotor agitation, poor cooperation, hallucinations, impairment of memory (consistent with organic brain syndrome).

Detailed neuropsychological examination after plasmapheresis à normal.

 

Routine laboratory examination:

Haemogram, serum electrolytes, thyroid function, liver function, lactate dehydrogenase, creatine kinase, pyruvic and lactic acid, anti-nuclear, anti-smooth muscle, anti-DNA, anti-thyroglobulin and anti-microsomal antibodies and tumoral markers (CEA, PAP, alpha1 fetoprotein, PSA, CA19-9, TPA, CT, SCG, TG) were all normal. Sedimentation rate à (49 mm/h).

The cerebrospinal fluid (CSF) à normal,

VDRL in CSF à negative

IgG index à normal

Weak oligoclonal bands in CSF. Absent in the serum.

Chest x-rays and CT à normal.

ECG à frequent supraventricular extrasystoles.

Urodynamic test à hyperreflexic bladder

 

Pathologic examination:

Muscle biopsy (left vastus lateralis) à angular and atrophic fibres (mild neurogenic involvement)

Autopsy à pulmonary adenocarcinoma. Adrenal glands are normal.

Pathologic examination of brain à no significant pathology

 

Neuroradiologic examination:

Brain MRI à high intensity lesions in white matter of both cerebral hemispheres

PET (after plasmapheresis) à normal

 

Electrophysiologic examination:

EMGà spontaneous occurrence of irregularly repetitive MUPs, complex repetitive discharges. No fibrillation potentials, normal insertional activity. No decrement or increment.

ENG à normal.

Video-PSG à NREM sleep findings (spindles, K complexes, delta waves) are absent, abnormal halucinatory movements (dream-like behavioural episodes).

EEG à wakefulness (abundant theta activity), short REM sleep phases, short muscle atonia duration

After plasmapheresis à almost normal

 

METHODS:

Radioimmunoassay (RIA): The presence of anti-voltage gated potassium channels anti-calcium activated potassium channels was assessed in all serum samples by RIA. Five ml of serum samples (diluted 1/10 in PTX) were incubated with 2.5 ml of 125I-labelled charybdotoxin (ChTx) (125000 cpm/assay tube) and 8 ml of 125I-labelled DTx (40000 cpm/assay tube) for 2 hours at room temperature. Then 500 ml of sheep anti-human IgG was added and the mixture was incubated overnight at 4°C. After centrifugation at 13000 rpm for 5 minutes, the precipitates were counted for 125I with a gamma scintillation counter.

Serum antibodies to AChR, VGCC, GAD, gangliosides, paraneoplastic antigens were also detected.

Immunohistochemistry: Serum of the patient was used for immunohistochemistry studies. Adult rat brain and foetal mouse head tissues were immediately frozen at -70°C until used for immunohistochemical studies. Consecutive 10 mm frozen sections were air dried. After fixation with 4% paraformaldehyde for 3 minutes and inhibition of endogenous peroxidase with 3% hydrogen peroxide in methanol for 10 minutes, the sections were incubated with 5% fetal coated serum for 10 minutes, serum samples (dilution 1/100) for 1 hour and horseradish peroxidase labelled rat anti-human IgG for 30 minutes at room temperature. The reaction was developed with AEC stock with hydrogen peroxide in acetate buffer in 20 minutes. Dilution of sera was done in PBS. Identification of anatomical localizations were performed by comparisons with an adult rat brain and foetal mouse brain atlas.

Autoradiography: Adult rat brain was used for 125I-labelled dendrotoxin (DTx) autoradiography and foetal mouse head tissues were used for both DTx and 125I-labelled charybdotoxin (ChTx) autoradiography. Ten mm frozen sections were mounted on slides and air dried. After fixation with aceton for 10 minutes, sections were incubated overnight with ChTx (14000 cpm/assay tube) and DTx (14000 to 70000 cpm/assay tube) at 4°C. After fixation with 4% paraformaldehyde for 5 minutes, the sections were rinsed with PBS and rehydrated with 70% and 95% ethanol, respectively. The sections were placed in the emulsion. The autoradiograms were obtained by using a developer and fixer. In order to identify anatomical localizations, sections were stained with hematoxylen eosin and compared with the adult rat brain and foetal mouse brain atlas.

 

RESULTS:

RIA: Serum antibodies to VGKC were strongly positive (633 pM). Anti-Ca activated K channel antibodies could not be detected. Serum antibodies to AChR, VGCC, GAD, gangliosides, paraneoplastic antigens were all negative.

IMMUNOHISTOCHEMISTRY:

Adult rat brain sections: Antibodies (1/800) bound strongly to neuronal cells in the cortex, hippocampus, medial thalamic structures and midbrain sparing the white matter.

Foetal mouse head sections: There was a high background in all gray matter including neocortex, hippocampus, caudate, putamen, globus pallidus, various nuclei of thalamus, hypothalamus, brain stem and cerebellum.

Antibodies binded most strongly to parafascicular nuclei, fasciculus retroflexus and lateral geniculate nuclei in thalamus, central nucleus of the inferior colliculus in midbrain, middle cerebellar peduncle and principal sensory trigeminal nucleus in pons and olivary nucleus in medulla.

The most prominent finding was the staining of both parafascicular nuclei and their tractus (fasciculus retroflexus), which are important structures in sleep physiology.  Lateral geniculate nuclei were other sleep related structures in thalamus that are also stained by patient’s serum.

AUTORADIOGRAPHY:

Adult rat brain sections: DTx showed a distribution in the rat brain, including many areas that serum antibodies bound. DTx showed more binding to the axonal tracts (e.g. corpus callosum), not as much binding to outer layers of cortex.

Foetal mouse head sections:

ChTx: There was a strong binding pattern on all cortical structures including hippocampus. Weak to moderate binding was observed in caudate-putamen and globus pallidus. There was weak staining on some hypothalamic nuclei and cerebellum. There was always some binding on tongue, muscles and salivary glands. There was no binding on choroid plexus,  pineal gland and subcutaneus tissue.

DTx: There was a strong binding pattern on all cortical structures including hippocampus. Moderate to strong binding on hypothalamic nuclei, caudate-putamen, globus pallidus, nucleus accumbens, pituitary gland was also present. There was always some binding on tongue, muscles and salivary glands and their ducts. Pineal gland, choroid plexus and subcutaneus tissue demonstrated strong binding, as well.

Parafascicular nucleus and fasciculus retroflexus did not reveal any binding with both ChTx and DTx.

The results of our study revealed two major evidences for differences between antigen expressions of adult and foetal medial thalamic structures: 1.Although patient’s serum stained parafascicular nuclei and their tractus strongly, no binding could be observed on these structures by autoradiography. So, foetal parafascicular nuclei did not seem to contain potassium channels. 2.The staining patterns observed on similar adult rat sections were different. Fasciculus retroflexus could not be recognized among various stained structures located in medial thalamus. Most probably, antibodies in patient’s serum were binding to antigens (potassium channel or other antigens) distributed in a more widespread area in medial thalamus and this prevented the identification of these structures.

 

DISCUSSION:

1.There is a large number of reports demonstrating the immaturity of thalamic nuclei and differences in antigen expression of newborn and foetal rodents. Voltage responses and current thresholds of VGKC of rat geniculate body reach to adult levels only after 13th postnatal day (7). Neurons of zona incerta exhibit very low amounts of surface proteoglycans in newborn mice, as compared to adults (8). Parvalbumin reactivity of thalamic reticular nuclei of rat increase gradually during maturation (9). All these observations and the results of our study may be possible indicators of observed differences between sleep-wake cycles of adults and newborns.

2.Some of the strongly stained structures (lateral geniculate nuclei, parafascicular nucleus and fasciculus retroflexus) contain high amounts of neuropeptide Y (NPY). NPY is usually an inhibitory neurotransmitter, plays an important role in sleep physiology and exert its effects via voltage-gated or calcium activated potassium channels in these anatomical structures (10). The foetal tissue antigens that were observed in fasciculus retroflexus and lateral geniculate nuclei but did not reveal any binding by VGKC blockers may be NPY or calcium activated potassium channels.

 

REFERENCES:

1.   Lee EK, Maselli RA, Ellis WG, Agius MA. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 1998, 65(6): 857-62.

2.   Haug BA, Schoenle PW, Karch BJ, Bardosi A, Holzgraefe M. Morvan's fibrillary chorea. A case with possible manganese poisoning. Clin Neurol Neurosurg 1989, 91(1): 53-9.

3.   Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology 2000, 54(3): 771-2.

4.   Murri L, Bonuccelli U, Iudice A, Simonetti C. Sleep disturbances in a case of Morvan's chorea. Riv Patol Nerv Ment 1976, 97(6): 350-6.

5.   Autret A, Henry-Le Bras F, Duvelleroy-Hommet C, Lucas B, de Toffol B. Agrypnia. Neurophysiol Clin 1995, 25(6): 360-6.

6.  Adrien de La Taille J. Ontogenesis and organization of sleep. Rev Prat 1989, 39(1): 5-9.

7.  Tennigkeit F, Schwarz DW, Puil E. Postnatal development of signal generation in auditory thalamic neurons. Brain Res Dev Brain Res 1998, 109(2): 255-63.

8.  Murakami T, Ohtsuka A, Taguchi T, Piao DX. Perineuronal sulfated proteoglycans and dark neurons in the brain and spinal cord: a histochemical and electron microscopic study of newborn and adult mice. Arch Histol Cytol 1995, 58(5): 557-65.

9.  Majak K, Berdel B, Kowianski P, Dziewiatkowski J, Lipowska M, Morys J. Parvalbumin immunoreactivity changes in the thalamic reticular nucleus during the maturation of the rat's brain. Folia Neuropathol 1998;36(1):7-14

Hall AC, Earle-Cruikshanks G, Harrington ME. Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y. Eur J Neurosci 1999, 11(10): 3424-32.